| Elements of Financial/Personal Conflicts |
*Author 1 Torke |
Author 2 Petronio |
Author 3 Purnell |
Author 4 Sachs |
Author 5 Helft |
Author 6 Callahan |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | |
| Employment or Affiliation | X | X | X | X | X | X | ||||||
| Grants/Funds | X | X | X | X | X | X | ||||||
| Honoraria | X | X | X | X | X | X | ||||||
| Speaker Forum | X | X | X | X | X | X | ||||||
| Consultant | X | X | X | X | X | X | ||||||
| Stocks | X | X | X | X | X | X | ||||||
| Royalties | X | X | X | X | X | X | ||||||
| Expert Testimony | X | X | X | X | X | X | ||||||
| Board Member | X | X | X | X | X | X | ||||||
| Patents | X | X | X | X | X | X | ||||||
| Personal Relationship | X | X | X | X | X | X | ||||||
Authors can be listed by abbreviations of their names
For “yes”, provide a brief explanation: _ Dr. Torke was supported by a Geriatrics Health Outcomes Research Scholars Award sponsored by the American Geriatrics Society and the John A. Hartford Foundation and a career development award from the National Institute on Aging (K23AG031323). She is also a consultant on a Retirement Research Foundation grant to the Wishard Volunteer Advocates Program, a public guardianship program for adults. Dr. Callahan is supported by a Midcareer Investigator Award in Patient Oriented Research (K24 4682309). These funders had no role in the design, methods, subject recruitment, data collections, analysis, or preparation of paper.
Dr. Sachs serves as a consultant to the National Pharmacy and Therapeutics Committee of CVS Caremark and he receives an honorarium for this role. Dr. Sachs is one of two individuals on the committee who were selected because of their specific geriatrics credentials and experience. If Dr. Sachs attends all four of the quarterly meetings, plus additional brief phone consultations, his annual compensation for these activities may total in the $12,000 to $15,000 range.
In this role for CVS Caremark, Dr. Sachs is asked to comment on and advise with respect to the safety and efficacy of medications as they are reviewed for inclusion on various formularies, preferred prescribing guides, and clinical programs. Attention is given to ensuring that patients’
health would not be put at risk by any formulary decisions. There is a strict “firewall” between this review process and business considerations of CVS Caremark such as prices, cost effectiveness, and contracts with clients or pharmaceutical firms (i.e., Dr. Sachs and other committee members are not privy to any of this other information).
Dr. Sachs’s own research program relates to ethical issues encountered in clinical care and research involving people with dementia, including end-of-life care issues. Dr. Sachs does not conduct medication trials and has no relationships with pharmaceutical or equipment companies.